GlassScriptPhysician profile
Kevin D Nolan
NPI 1871560979
$13,069.04
in general payments reported to CMS, 2019-2025
25 companies · $3,194 in 2025
The $3,194 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,975 · 2020: $345 · 2021: $776 · 2022: $3,678 · 2023: $1,162 · 2024: $940 · 2025: $3,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,651 · Travel and Lodging: $1,366 · Education: $678 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,650.95 |
| Travel and Lodging | $1,366.01 |
| Education | $678.20 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $4,141.44 | 2019-2023 | Alto Abdominal Stent Graft System |
| Abbott Laboratories | $2,326.00 | 2019-2024 | Supera, Jeti |
| Ets Wound Care LLC | $2,204.75 | 2025 | Mirragen Advanced Wound Matrix |
| Organogenesis INC. | $1,140.03 | 2021-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Smith+Nephew, INC. | $689.73 | 2019-2025 | Pico 7, Oasis, Grafix |
| Silk Road Medical, INC. | $346.18 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Mimedx Group, INC. | $333.27 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $330.44 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $289.21 | 2019-2021 | |
| Medtronic, INC. | $179.23 | 2023-2025 | Abre, Hawkone |
| Inari Medical, INC. | $159.70 | 2022 | |
| Solventum Corporation | $158.67 | 2024-2025 | Activ.A.C., Snap |
| Osiris Therapeutics INC. | $129.74 | 2019 | |
| Venclose INC. | $119.90 | 2020 | |
| Angiodynamics, INC. | $90.72 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $75.43 | 2021 | |
| Boston Scientific Corporation | $68.14 | 2021-2023 | Eluvia |
| Siemens Medical Solutions USA, INC. | $64.30 | 2019-2020 | |
| Cordis US Corp. | $50.32 | 2025 | Mynxgrip, Mynx Control |
| Veryan Medical Incorporated | $47.54 | 2021 | |
| Bard Peripheral Vascular, INC. | $34.61 | 2019-2021 | |
| Bolton Medical INC | $25.46 | 2019 | |
| Cook Medical LLC | $23.36 | 2025 | Cook |
| Penumbra, INC. | $22.04 | 2020-2021 | |
| Argon Medical Devices, INC. | $18.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.